Connect with us


Ottawa sets new single-day high with 240 COVID-19 cases –



  • Ottawa is reporting 240 more COVID-19 cases and one new death, representing the single largest one-day total of the pandemic so far. 
  • Across the river in western Quebec, 131 cases were reported.

Today’s Ottawa update

Ottawa Public Health (OPH) recorded 240 more COVID-19 cases on Saturday, the highest single-day case total of the pandemic. 

Another 81 cases are considered resolved. One new death was also reported, bringing the total number of deaths to 467.

The number of known active cases across the city stands at 1,516. 

There are 44 people in hospitals across the city suffering from the illness,14 of whom are in intensive care.

Ontario is now under a provincewide shutdown. Here is what that means for the Ottawa region.

OPH said Wednesday it can’t keep up with contact tracing and its testing and hospital capacity are being strained by the surge of cases. 

Numbers to watch

104.3: The weekly incidence rate, a rolling seven-day total of new COVID-19 cases expressed per 100,000 residents, rises. It  has entered the triple digits for the first time. 

152.8: The seven-day average of new cases per day is on the rise, which also reached a new high on Saturday.

6.5%: The percentage of COVID-19 tests coming back positive has surged in recent days.

1.13: The number of people infected by a single COVID-19 case, or R(t). The spread of the coronavirus is considered under control if that figure is below one; it’s been above one for more than two weeks.

596: The number of confirmed and suspected coronavirus variant cases in Ottawa. The number has also surged in recent weeks.

Across the region

In western Quebec officials reported 131 new cases of COVID-19 on Saturday but no new deaths. 

Let’s block ads! (Why?)

Source link

Continue Reading


COVID cases in Ontario could spike to 30,000 per day by June



TORONTO (Reuters) – New cases of COVID-19 in Canada‘s most populous province could rise more than six fold, topping 30,000 per day by early June if public health measures are weak and vaccination rates remain flat, a panel of experts advising the province of Ontario said on Friday.

Even if measures to control the virus are “moderate,” the number of patients in Ontario ICUs could reach 2,000 in May, up from 695 on Friday.

The College of Physicians and Surgeons of Ontario told doctors last week they may soon have to decide who can and cannot receive intensive care.


(Reporting by Allison Martell; Editing by Chris Reese)

Continue Reading


Moderna sees shortfall in Britain COVID vaccine shipments, EU deliveries on track



ZURICH (Reuters) – U.S. drugmaker Moderna expects a shortfall in COVID-19 vaccine doses from its European supply chain hitting second-quarter delivery quantities for Britain and Canada, though European Union– and Swiss-bound shipments are on track, a spokesperson said.

The delays, first announced on Friday when Canada said Moderna would be delivering only about half the planned 1.2 million doses by the end of April, come as Switzerland’s Lonza ramps up three new production lines to make active ingredients for Moderna vaccine supplies outside of the United States.

“The trajectory of vaccine manufacturing ramp-up is not linear, and despite best efforts, there is a shortfall in previously estimated doses from the European supply chain,” Moderna said in a statement.

Lonza didn’t immediately return a phone call and email seeking comment on any issues in its production.


(Reporting by John Miller; editing by David Evans)

Continue Reading


Moderna says vaccines to Canada to be delayed due to Europe shortfall



(Reuters) -Moderna Inc said on Friday a shortfall in COVID-19 vaccine doses from its European supply chain will lead to a delay in deliveries to some countries including Canada.

The drugmaker would be delivering only 650,000 doses by April end as opposed to 1.2 million, Canada‘s Procurement Minister Anita Anand said in a statement.

She said one to two million doses of the 12.3 million doses scheduled for delivery by Moderna in the second quarter would be delayed until the third.

Moderna officials in Europe did not immediately comment on the reason for the delays or give the total number of countries that would be impacted.

“Vaccine manufacturing is a highly complex process and a number of elements, including human and material resources have factored into this volatility,” said Patricia Gauthier, an executive at Moderna Canada.

Canada has distributed a total of 2.82 million doses of the Moderna vaccine as of April 14 and 12.7 million doses of COVID-19 vaccines in total.

Moderna has been aiming to deliver 700 million to 1 billion doses of the COVID-19 globally this year, including from plants in Europe and the United States.

Swiss contract drug manufacturer Lonza makes active ingredients for Moderna’s vaccine in Visp, but it was still ramping up three new production lines that once operational would be able to produce 300 million shots annually.

The current supply, demand and distribution landscape has led the drugmaker to make adjustments in the expected second-quarter deliveries, Gauthier said.

(Reporting by Manas Mishra in Bengaluru, Allison Martell in Toronto and John Miller in Zurich; Editing by Arun Koyyur)

Continue Reading